News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,950 Results
Type
Article (13654)
Company Profile (108)
Press Release (249188)
Section
Business (88011)
Career Advice (464)
Deals (15348)
Drug Delivery (64)
Drug Development (36595)
Employer Resources (49)
FDA (6273)
Job Trends (6190)
News (150181)
Policy (14018)
Tag
Academia (435)
Alliances (23167)
Alzheimer's disease (370)
Approvals (6285)
Artificial intelligence (72)
Bankruptcy (144)
Best Places to Work (4357)
Breast cancer (64)
Cancer (448)
Cardiovascular disease (46)
Career advice (406)
Cell therapy (60)
Clinical research (30662)
Collaboration (230)
Compensation (100)
COVID-19 (751)
C-suite (74)
Data (448)
Diabetes (64)
Diagnostics (1246)
Drug discovery (45)
Drug pricing (59)
Earnings (31654)
Events (37045)
Executive appointments (257)
FDA (6536)
Funding (152)
Gene therapy (72)
GLP-1 (313)
Government (1273)
Healthcare (3545)
Infectious disease (773)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5857)
Job creations (2050)
Job search strategy (372)
Layoffs (170)
Legal (3416)
Lung cancer (63)
Manufacturing (112)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9591)
Metabolic disorders (198)
Neuroscience (492)
NextGen: Class of 2025 (1581)
Non-profit (591)
Northern California (545)
Obesity (118)
Opinion (113)
Patents (70)
People (28648)
Pharmaceutical (67)
Phase I (7976)
Phase II (12961)
Phase III (11658)
Pipeline (230)
Policy (47)
Postmarket research (1400)
Preclinical (3180)
Radiopharmaceuticals (116)
Rare diseases (115)
Real estate (2631)
Regulatory (9930)
Research institute (563)
Resumes & cover letters (55)
Southern California (538)
Startups (1625)
United States (5321)
Vaccines (120)
Weight loss (86)
Date
Today (10)
Last 7 days (179)
Last 30 days (678)
Last 365 days (12414)
2025 (584)
2024 (12555)
2023 (14291)
2022 (19604)
2021 (20103)
2020 (19065)
2019 (14893)
2018 (11715)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (45)
Asia (19934)
Australia (2572)
California (1287)
Canada (716)
China (168)
Colorado (51)
Connecticut (54)
Europe (39009)
Florida (209)
Illinois (145)
Indiana (103)
Japan (59)
Kansas (53)
Maryland (185)
Massachusetts (1103)
Minnesota (70)
New Jersey (527)
New York (358)
North Carolina (314)
Northern California (545)
Pennsylvania (336)
South America (500)
Southern California (538)
Texas (167)
Virginia (49)
Washington State (85)
262,950 Results for "arcutis pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arcutis Announces Promotions on Executive Management Team
December 3, 2024
·
5 min read
Biotech Bay
Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Arcutis Biotherapeutics, Inc. today announced that Arcutis management will participate in the Goldman Sachs 45th Annual Global Healthcare Conference, taking place June 10-13, 2024.
June 3, 2024
·
2 min read
Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 6, 2025
January 7, 2025
·
3 min read
Approvals
FDA Approves Atopic Dermatitis Label Expansion for Arcutis’ Zoryve Cream
The regulator Tuesday added atopic dermatitis to the label of Arcutis Biotherapeutics’ topical PDE4 inhibitor Zoryve for the treatment of patients six years of age and older.
July 10, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Arcutis Announces Preliminary Unaudited Fourth Quarter Product Revenue and Full-Year 2024 Product Revenues of Approximately $63 Million and $160 Million
January 13, 2025
·
6 min read
Press Releases
Arcutis Announces Third Quarter 2024 Financial Results and Provides Business Update
November 7, 2024
·
13 min read
Biotech Beach
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 05, 2024
Arcutis Biotherapeutics, Inc., a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, reported the grant of an aggregate of 57,500 restricted stock units of Arcutis’ common stock to six newly hired employees.
June 5, 2024
·
3 min read
Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 6, 2024
December 9, 2024
·
3 min read
Biotech Beach
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 03, 2024
Arcutis Biotherapeutics, Inc. reported the grant of an aggregate of 160,500 restricted stock units of Arcutis’ common stock as well as options to purchase an aggregate of 117,000 shares of Arcutis’ common stock to 13 newly hired employees.
May 3, 2024
·
3 min read
Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 4, 2024
·
3 min read
1 of 26,295
Next
